Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
- PMID: 8446617
- PMCID: PMC46003
- DOI: 10.1073/pnas.90.5.1977
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
Abstract
Apolipoprotein E is immunochemically localized to the senile plaques, vascular amyloid, and neurofibrillary tangles of Alzheimer disease. In vitro, apolipoprotein E in cerebrospinal fluid binds to synthetic beta A4 peptide (the primary constituent of the senile plaque) with high avidity. Amino acids 12-28 of the beta A4 peptide are required. The gene for apolipoprotein E is located on chromosome 19q13.2, within the region previously associated with linkage of late-onset familial Alzheimer disease. Analysis of apolipoprotein E alleles in Alzheimer disease and controls demonstrated that there was a highly significant association of apolipoprotein E type 4 allele (APOE-epsilon 4) and late-onset familial Alzheimer disease. The allele frequency of the APOE-epsilon 4 in 30 random affected patients, each from a different Alzheimer disease family, was 0.50 +/- 0.06; the allele frequency of APOE-epsilon 4 in 91 age-matched unrelated controls was 0.16 +/- 0.03 (Z = 2.44, P = 0.014). A functional role of the apolipoprotein E-E4 isoform in the pathogenesis of late-onset familial Alzheimer disease is suggested.
Similar articles
-
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8098-102. doi: 10.1073/pnas.90.17.8098. Proc Natl Acad Sci U S A. 1993. PMID: 8367470 Free PMC article.
-
[Apolipoprotein E4 and late-onset Alzheimer's disease].Nihon Rinsho. 1994 Dec;52(12):3257-65. Nihon Rinsho. 1994. PMID: 7853720 Review. Japanese.
-
Apolipoprotein E polymorphism and Alzheimer's disease.Lancet. 1993 Sep 18;342(8873):697-9. doi: 10.1016/0140-6736(93)91705-q. Lancet. 1993. PMID: 8103819
-
Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):515-7. doi: 10.1136/jnnp.2005.063917. J Neurol Neurosurg Psychiatry. 2006. PMID: 16543533 Free PMC article.
-
[Lipoproteins in clinical laboratory medicine].Rinsho Byori. 1998 Dec;46(12):1219-25. Rinsho Byori. 1998. PMID: 9916507 Review. Japanese.
Cited by
-
APOE from astrocytes restores Alzheimer's Aβ-pathology and DAM-like responses in APOE deficient microglia.EMBO Mol Med. 2024 Nov 11. doi: 10.1038/s44321-024-00162-7. Online ahead of print. EMBO Mol Med. 2024. PMID: 39528861
-
The mTOR Pathway: A Common Link Between Alzheimer's Disease and Down Syndrome.J Clin Med. 2024 Oct 17;13(20):6183. doi: 10.3390/jcm13206183. J Clin Med. 2024. PMID: 39458132 Free PMC article. Review.
-
Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a Mendelian randomization analysis.Alzheimers Res Ther. 2024 Oct 16;16(1):228. doi: 10.1186/s13195-024-01594-6. Alzheimers Res Ther. 2024. PMID: 39415269 Free PMC article.
-
Apolipoprotein E and Alzheimer's Disease in Italian Population: Systematic Review and Meta-Analysis.Brain Sci. 2024 Sep 7;14(9):908. doi: 10.3390/brainsci14090908. Brain Sci. 2024. PMID: 39335404 Free PMC article. Review.
-
Editorial: Meeting new challenges in translationally relevant neurodegenerative disease research.Front Neurosci. 2024 Aug 22;18:1453770. doi: 10.3389/fnins.2024.1453770. eCollection 2024. Front Neurosci. 2024. PMID: 39238927 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
